Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema

British Journal of Dermatology

Volumn 148, Issue 5, 2003, Pages 1010-1017

  Ravenscroft, J C ^a,c   Layton, A M ^a   Eady, E A ^b   Murtagh, M S ^b   Coates, P ^b   Walker, M ^a   Cove, J H ^b  

^a HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Atopic eczema; Fusidic acid; Mupirocin; Resistance; Staphylococcus aureus

Indexed keywords

BETAMETHASONE VALERATE; DIPROBASE; EMOLLIENT AGENT; FUSIDIC ACID; OIL; PSEUDOMONIC ACID; STEROID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIUM CARRIER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG POTENCY; ECZEMA; FEMALE; FUCIBET; HUMAN; HYPOTHESIS; MALE; NOSE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SKIN; SKIN IRRITATION; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DRUG RESISTANCE, MICROBIAL; FEMALE; FUSIDIC ACID; HUMANS; MALE; MIDDLE AGED; MUPIROCIN; SEX FACTORS; STAPHYLOCOCCUS AUREUS; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 0038539486     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05292.x     Document Type: Article

References (23)

1. Ravenscroft JC, Layton A, Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire. UK. Exp Dermatol 2000; 25: 327-30.
2. Reed J, Lyons M, Waghorn D, Wilkinson J. Fusidic acid resistance rates in South Buckinghamshire. Br J Dermatol 1999; 141 (Suppl. 55): 57 (Abstr.).
3. Simpson SL, Hunt SJ, Hardman C et al. Rates of fusidic acid resistance in paediatric dermatology patients - a 6-year study. Br J Dermatol 2000; 143 (Suppl. 57): 127 (Abstr.).
4. O'Neill AJ, Cove JH, Chopra I. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother 2001; 47: 647-50.
5. Eady EA. Bacterial resistance in acne. Dermatology 1998; 196: 59-66.
6. Perl TM, Golub JE. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother 1998; 32 (Suppl.): S7-16.
7. Williams JV, Vowels BR, Honig P, Leyden JJ. S. aureus isolation from the lesions, the hands, and the anterior nares of patients with atopic dermatitis. Pediatr Dermatol 1998; 15: 194-8.
8. Von Eiff C, Becker K, Machka K et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344: 11-16.
9. Toshkova K, Annemuller C, Akineden O, Lammler C. The significance of Staphylococcus aureus as a risk factor for human skin infections. FEMS Microbiol Lett 2001; 202: 17-24.
10. Morley PA, Munot LD. A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis. Curr Med Res Opin 1988; 11: 142-8.
11. White DG, Collins PO, Rowsell RB. Topical antibiotics in the treatment of superficial skin infections in general practice - a comparison of mupirocin with sodium fusidate. J Infect 1989; 18: 221-9.
12. Costa C, Rillet A, Nicolet M et al. Scoring atopic dermatitis: the simpler the better? Acta Derm Venereol (Stockh) 1989; 69: 41-5.
13. Williamson P, Kligman AM. A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol 1965; 45: 498-503.
14. Coates P, Vyakrnam S, Eady EA et al. Prevalence of antibiotic resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol 2002; 146: 840-8.
15. Kucers A, Bennett N. The Use of Antibiotics. 4th edn. London: Heineman Medical Books. 1987.
16. Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. J Antimicrob Chemother 1991; 27 (Suppl. D): 1-50.
17. Drancourt M, Stein A, Argenson JN et al. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother 1997; 39: 235-40.
18. Bojar RA, Eady EA, Jones CE et al. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. Br J Dermatol 1994; 130: 329-6.
19. Murtagh MS. Fusidic acid resistance in Staphylococcus aureus. University of Leeds MSc Thesis, 2000.
20. Johnson R, Nusbaum BP, Horwitz SN, Frost P. Transfer of topically applied tetracycline in various vehicles. Arch Dermatol 1983; 119: 660-3.
21. Aly R, Maibach HI, Shinefield HR. Microbiology of atopic dermatitis. Arch Dermatol 1977; 113: 780-2.
22. Dhar S, Kanwar AJ, Kaur S et al. Role of bacterial flora in the pathogenesis and management of atopic dermatitis. Indian J Med Res 1992; 95: 234-8.
23. Nishijima S, Namura S, Higashida T, Kawai S. Staphylococcus aureus in the anterior nares and subungual spaces of the hands in atopic dermatitis. J Int Med Res 1997; 25: 155-8.